Chronic Venous Insufficiency Market to Show Immense Growth at a CAGR of 9.5% by 2034 | DelveInsight [Yahoo! Finance]
enVVeno Medical Corporation (NVNO)
Company Research
Source: Yahoo! Finance
promising emerging treatment options by leading companies such as Verigraft AB, enVVeno Medical Corporation, Theraclion, and others. LAS VEGAS Sept. 4, 2024 /PRNewswire/ -- DelveInsight's Chronic Venous Insufficiency Market Insights report includes a comprehensive understanding of current treatment practices, chronic venous insufficiency emerging drugs/devices, market share of individual therapies/devices, and current and forecasted market size from 2020 to 2034, segmented into 7MM [ the United States , the EU4 ( Germany France Italy , and Spain ) and the United Kingdom , and Japan]. Key Takeaways from the Chronic Venous Insufficiency Market Report According to DelveInsight's analysis, the market size for chronic venous insufficiency was found to be ~ USD 2 billion in the 7MM in 2023. Among all the non-pharmacological treatments, laser ablation/radiofrequency ablation is expected to generate the highest revenue followed by Surgery in the 7MM by 2034. In the 7MM, the US accou
Show less
Read more
Impact Snapshot
Event Time:
NVNO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVNO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVNO alerts
High impacting enVVeno Medical Corporation news events
Weekly update
A roundup of the hottest topics
NVNO
News
- enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium [Yahoo! Finance]Yahoo! Finance
- enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH SymposiumAccesswire
- enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval [Yahoo! Finance]Yahoo! Finance
- enVVeno Medical Submits the VenoValve PMA Application Seeking FDA ApprovalAccesswire
- Coronary Artery Bypass Graft Surgery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Report [Yahoo! Finance]Yahoo! Finance
NVNO
Sec Filings
- 11/19/24 - Form DEF
- 11/14/24 - Form SCHEDULE
- 11/14/24 - Form SC
- NVNO's page on the SEC website